PTK2B and central nervous system cancer: In vitro experiments using several established glioma cell lines (A172, U87, HS683 and GL261) demonstrated that cells with higher levels of Pyk2 expression and phosphorylation exhibited greater invasive capacity, whereas those with lower basal Pyk2 activity showed limited migration and invasiveness.